Patient Preferences for Hepatocellular Carcinoma Surveillance Parameters is a research paper published in Clinical Gastroenterology and Hepatology (2021). On theSindex it has a DataRank of 0. It has been cited 68 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: R01 212008
National Institutes of Health
Grant: R01 MD12565
National Institutes of Health
Grant: U01 CA230694
National Institutes of Health
Grant: U01 CA230669
NIMHD NIH HHS
Grant: R01 MD012565
NIDDK NIH HHS
Grant: T32 DK062708
NCI NIH HHS
Grant: R01 CA212008
Allergan
Grant: unidentified
unidentified
National Institutes of Health
Grant: 5R01CA212008-03
Harms of Hepatocellular Carcinoma Screening in Patients with Cirrhosis
National Institutes of Health
Grant: 3R01MD012565-03S1
Multilevel factors for racial/ethnic and socioeconomic disparities in prognosis of hepatocellular carcinoma
National Institutes of Health
Grant: 5U01CA230694-03
Precision Risk Stratification and Screening for HCC among Patients with Cirrhosis in the United States
National Institutes of Health
Grant: 5U01CA230669-05
NOVEL STRATEGIES TO IMPROVE LIVER CANCER SURVEILLANCE UPTAKE AND EARLY DETECTION
Allergan
Genentech
Eisai
Takeda Pharmaceuticals U.S.A.
Bayer
Exelixis
Novo Nordisk
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals